5.000GBp-1.96%Mkt Cap: 5.89M GBpP/E: —Last update: 2026-05-13
OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally. The company identifi…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
P/B0.70
P/S5.16
EV/EBITDA-1.91
EV/Revenue4.03
EPS (TTM)0.00
EPS (Forward)—
Cash Flow & Leverage
FCF Yield-15.51%
FCF Margin-79.33%
Operating CF-1.77M GBp
CapEx (TTM)—
Net Debt/EBITDA0.53
Net Debt-1.30M GBp
Technical
SMA 505.370 (-6.9%)
SMA 2007.641 (-34.6%)
Beta1.80
S&P 52W Chg24.23%
Avg Vol (30d)426.66K
Avg Vol (10d)431.01K
Technical Indicators
RSI (14)37.5
MACD-0.1292
MACD Signal-0.1495
MACD Hist.+0.0202
BB Upper5.546 GBp
BB Middle5.168 GBp
BB Lower4.789 GBp
BB Width14.66%
ATR (14)0.3400 GBp
Vol Ratio (20d)11.16x
52W Range
4.5003% of range19.40
52W High19.40 GBp
52W Low4.500 GBp
Profitability
Gross Margin38.05%
EBITDA Margin-211.30%
Profit Margin-207.47%
Oper. Margin-257.99%
ROE-21.49%
ROA-19.96%
Revenue Growth101.80%
Earnings Growth—
Balance Sheet
Debt/Equity—
Current Ratio4.61
Quick Ratio3.75
Book Value/Sh0.0820 GBp
Cash/Share0.0130 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:200
Split DateAug 5, 2014
Ownership
Shares Out.103.30M
Float92.81M
Insiders11.53%
Institutions7.74%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap5.89M GBp
Enterprise Value4.64M GBp
Revenue (TTM)1.15M GBp
Gross Profit331.00K GBp
Net Income (TTM)-1.80M GBp
Revenue/Share0.0110 GBp
Fiscal Year EndDec 2024
MR QuarterJun 2025
Employees10
Last Price5.000 GBp
CountryGB
SectorHealthcare
IndustryBiotechnology
ISINCA68405H1001